{"cord_uid": "e66o5j85", "sourcedb": "PMC", "sourceid": "PMC4687909", "divid": "32", "text": "We observed similar results in a different context . Despite the dearth of vaccination against pneumococcus in our population , viral pneumonia is a major segment of the pneumonia burden . Treatment of these infections is often problematic because the empirical use of antibiotics or antivirals is not consensual [ 25 ] . Vaccine development , particularly against RSV , is warranted to prevent pneumonia in children . Moreover , the impact of influenza vaccine policies in developing countries should be evaluated because this virus often causes pneumonia [ 26 ] .", "project": "cdlai_CORD-19", "denotations": [{"id": "A-biobert_T1", "span": {"begin": 128, "end": 144}, "obj": "Disease"}, {"id": "A-biobert_T2", "span": {"begin": 170, "end": 180}, "obj": "Disease"}, {"id": "A-biobert_T3", "span": {"begin": 395, "end": 405}, "obj": "Disease"}, {"id": "A-biobert_T4", "span": {"begin": 547, "end": 557}, "obj": "Disease"}]}